Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner
- Status
- TERMINATED
- Phase
- N/A
Preoperative Chemoradiation for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Spatial Analysis and Validation of Glioblastoma on 7 T MRI
- Status
- TERMINATED
- Phase
- NA
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
- Status
- UNKNOWN
- Phase
- N/A
Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
- Status
- TERMINATED
- Phase
- NA
Image Guided Reirradiation of High-grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
- Status
- TERMINATED
- Phase
- PHASE2
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
- Status
- COMPLETED
- Phase
- PHASE1
ANG1005 in Patients With Recurrent High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1